Exploring Acne Treatments Through Clinical Research Participation
Launched by POWER LIFE SCIENCES INC. · May 30, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to learn more about the experiences of people with acne who are part of another study testing a specific treatment. Researchers want to understand how well patients stick to the treatment plan and why some may drop out of the study. This information will help improve future research and care, especially for those who might not have easy access to treatment.
To be eligible for this trial, participants need to be at least 18 years old and diagnosed with acne. They should also be able to give written consent to join the study and follow the treatment plan, which includes attending scheduled visits. However, women who are pregnant or breastfeeding, and those with serious medical conditions that could affect their health, cannot participate. While the study isn’t recruiting yet, those who qualify can expect to share their experiences and help researchers develop better acne treatments for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with acne.
- • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- • Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
- Exclusion Criteria:
- • Refusal of consent
- • Women of childbearing potential without a negative pregnancy test; or women who are lactating.
- • Any serious and/or unstable pre-existing medical disorders
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported